ASX - By Stock
|
AVR |
Re:
ADAPT TAVR -Just Better
|
|
nwilliams
|
88 |
30K |
14 |
24/09/17 |
24/09/17 |
ASX - By Stock
|
88
|
30K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
ADAPT TAVR -Just Better
|
|
nwilliams
|
88 |
30K |
32 |
23/09/17 |
23/09/17 |
ASX - By Stock
|
88
|
30K
|
32
|
|
ASX - By Stock
|
AVR |
Re:
ADAPT TAVR -Just Better
|
|
nwilliams
|
88 |
30K |
14 |
22/09/17 |
22/09/17 |
ASX - By Stock
|
88
|
30K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
AHZ-- 100 baggers
|
|
nwilliams
|
125 |
47K |
24 |
15/09/17 |
15/09/17 |
ASX - By Stock
|
125
|
47K
|
24
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Webinar Presentation
|
|
nwilliams
|
95 |
29K |
8 |
07/09/17 |
07/09/17 |
ASX - By Stock
|
95
|
29K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
My thoughts on AHZ
|
|
nwilliams
|
241 |
85K |
1 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
241
|
85K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
My thoughts on AHZ
|
|
nwilliams
|
241 |
85K |
23 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
241
|
85K
|
23
|
|
ASX - By Stock
|
AVR |
Re:
Professor Neethling named VP of Cardiovascular Technologies
|
|
nwilliams
|
40 |
10K |
14 |
03/08/17 |
03/08/17 |
ASX - By Stock
|
40
|
10K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Professor Neethling named VP of Cardiovascular Technologies
|
|
nwilliams
|
40 |
10K |
16 |
03/08/17 |
03/08/17 |
ASX - By Stock
|
40
|
10K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
nwilliams
|
89 |
21K |
14 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
nwilliams
|
160 |
48K |
10 |
27/07/17 |
27/07/17 |
ASX - By Stock
|
160
|
48K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
nwilliams
|
160 |
48K |
6 |
26/07/17 |
26/07/17 |
ASX - By Stock
|
160
|
48K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Questions for Webinar
|
|
nwilliams
|
111 |
34K |
10 |
14/07/17 |
14/07/17 |
ASX - By Stock
|
111
|
34K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Questions for Webinar
|
|
nwilliams
|
111 |
34K |
27 |
14/07/17 |
14/07/17 |
ASX - By Stock
|
111
|
34K
|
27
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
11 |
02/06/17 |
02/06/17 |
ASX - By Stock
|
1.2K
|
445K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
8 |
02/06/17 |
02/06/17 |
ASX - By Stock
|
1.2K
|
445K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
16 |
02/06/17 |
02/06/17 |
ASX - By Stock
|
1.2K
|
445K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Looking forward
|
|
nwilliams
|
22 |
10K |
24 |
28/05/17 |
28/05/17 |
ASX - By Stock
|
22
|
10K
|
24
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
7 |
22/05/17 |
22/05/17 |
ASX - By Stock
|
1.2K
|
445K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
21 |
15/05/17 |
15/05/17 |
ASX - By Stock
|
1.2K
|
445K
|
21
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
3 |
13/05/17 |
13/05/17 |
ASX - By Stock
|
1.2K
|
445K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
4 |
13/05/17 |
13/05/17 |
ASX - By Stock
|
1.2K
|
445K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
nwilliams
|
350 |
143K |
2 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
350
|
143K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
nwilliams
|
350 |
143K |
12 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
350
|
143K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
nwilliams
|
350 |
143K |
11 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
350
|
143K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Tissue Engineering v. Immunotherapy
|
|
nwilliams
|
18 |
6.1K |
9 |
05/05/17 |
05/05/17 |
ASX - By Stock
|
18
|
6.1K
|
9
|
|
ASX - By Stock
|
MSP |
Re:
Ann: Appendix 4C - quarterly
|
|
nwilliams
|
129 |
46K |
3 |
03/05/17 |
03/05/17 |
ASX - By Stock
|
129
|
46K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Result Presented Next Week
|
|
nwilliams
|
72 |
30K |
8 |
27/04/17 |
27/04/17 |
ASX - By Stock
|
72
|
30K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
The approaching quarterly - hold tight.
|
|
nwilliams
|
9 |
3.9K |
4 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
9
|
3.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
The approaching quarterly - hold tight.
|
|
nwilliams
|
9 |
3.9K |
0 |
26/04/17 |
26/04/17 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
3 |
25/04/17 |
25/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
4 |
15/04/17 |
15/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
4 |
15/04/17 |
15/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
12 |
15/04/17 |
15/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
3 |
15/04/17 |
15/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
8 |
15/04/17 |
15/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
nwilliams
|
1.2K |
445K |
14 |
14/04/17 |
14/04/17 |
ASX - By Stock
|
1.2K
|
445K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
hsv2 final results
|
|
nwilliams
|
99 |
39K |
13 |
09/04/17 |
09/04/17 |
ASX - By Stock
|
99
|
39K
|
13
|
|
Charts
|
NTI |
Re:
NTI Chart
|
|
nwilliams
|
377 |
120K |
11 |
04/04/17 |
04/04/17 |
Charts
|
377
|
120K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
CardioCel 3D - A revolution is coming.
|
|
nwilliams
|
129 |
50K |
0 |
31/03/17 |
31/03/17 |
ASX - By Stock
|
129
|
50K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial
|
|
nwilliams
|
29 |
10K |
8 |
30/03/17 |
30/03/17 |
ASX - By Stock
|
29
|
10K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Export and Import Approvals for Clinical Studies Received
|
|
nwilliams
|
20 |
9.2K |
9 |
24/03/17 |
24/03/17 |
ASX - By Stock
|
20
|
9.2K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Another rise coming?
|
|
nwilliams
|
26 |
8.5K |
5 |
21/03/17 |
21/03/17 |
ASX - By Stock
|
26
|
8.5K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints Wayne Paterson as CEO
|
|
nwilliams
|
121 |
46K |
11 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
121
|
46K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
CardioCel 3D - A revolution is coming.
|
|
nwilliams
|
129 |
50K |
4 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
129
|
50K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
nwilliams
|
233 |
75K |
13 |
03/03/17 |
03/03/17 |
ASX - By Stock
|
233
|
75K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
nwilliams
|
233 |
75K |
1 |
02/03/17 |
02/03/17 |
ASX - By Stock
|
233
|
75K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Shareholder Webinar
|
|
nwilliams
|
233 |
75K |
0 |
02/03/17 |
02/03/17 |
ASX - By Stock
|
233
|
75K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
nwilliams
|
210 |
68K |
20 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
Admedus appoints new public relations consultant
|
|
nwilliams
|
15 |
5.8K |
10 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
15
|
5.8K
|
10
|
|